RadioClash Inc.
StreetZero Signal 56
About RadioClash Inc.
RadioClash, Inc. is a physician-led medical device company focused on developing enhanced electroporation therapy for advanced cancer therapeutics. The company is based in Houston, Texas and was founded in 2020. It aims to improve and expand definitive interventional treatment options for a cancer-free world through combination electroporation therapy.
LATEST FUNDINGPrivate Placement
$100K
Announced 2026-11-03
TOTAL RAISED$807K
IN THE NEWS
- 🔗 RadioClash - 2026 Company Profile, Funding & Competitors - Tracxn
- 🔗 RadioClash - 2026 Funding Rounds & List of Investors - Tracxn
- 🔗 RadioClash Inc.
- 🔗 RadioClash 2026 Company Profile: Valuation, Funding & Investors | PitchBook
- 🔗 RadioClash Inc. 2026: Is It Legit? Form D Raise, Investors, Who Is Behind It | AltStreet
EMPLOYEES—
FOUNDED2020
HQHouston, Texas, United States
Industry
Other Technology
Tags
BiotechnologyMedical DeviceCancer Therapy
Investors
Key highlights
- Physician-led company developing electroporation therapy for advanced cancers.
- Completed a Seed round in November 2024.
- Headquartered in Houston with connections to Texas Medical Center.
- Applied to TMC Innovation Accelerator for device funding.
Ask StreetZero about RadioClash Inc.
Put our AI to work on this deal.
Similar companies
Other Other Technology deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account